Retatrutide
Triple-receptor research compound. GLP-1 / GIP / glucagon pathway investigation.
RESTRICTED ACCESS
All products on this site are research chemicals sold strictly for laboratory and analytical purposes. Not for human or animal consumption. Confirm the following to enter.
I do not agree, exitMETABOLIC & GLP-1
GLP-1 receptor agonist research peptide. Glucose and metabolic-pathway investigation.
ABOUT THIS COMPOUND
Semaglutide is a synthetic GLP-1 receptor agonist research peptide. It is structurally analogous to native human GLP-1 (7-37) and engineered for extended half-life through albumin binding.
Widely studied in metabolic and glucose-pathway research, Semaglutide is one of the most-investigated GLP-1 agonists in the literature. Synthesized in our U.S. facility, HPLC-verified, and lyophilized under inert atmosphere.
SPECIFICATIONS
RESEARCH APPLICATIONS
All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.
QUALITY ASSURANCE
A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →
YOU MAY ALSO RESEARCH
QUESTIONS?
Lot questions, COA requests, institutional accounts, reach the team directly.
CONTACT US